Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-19FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
The FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC.
-
CLINICAL_TRIALS research · 2017-01-10Clinical Trial Update: Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
An update on a completed clinical trial evaluating circulating tumor cells as a blood-based biomarker in patients with small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating combination chemotherapy with or without filgrastim in patients with previously untreated extensive-stage small c…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of chemotherapy with exisulind in patients with extensive-stage small cell lung cancer has…
-
CLINICAL_TRIALS withdrawal · 2016-12-07Clinical Trial Update: A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients [Phase 1, Phase 2]
This Phase 1/Phase 2 trial evaluating CDX-1401 in combination with Poly-ICLC and pembrolizumab for previously treated advanced solid tumors …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer [Phase 4]
A Phase 4 clinical trial update comparing Irinotecan plus Cisplatin with Etoposide plus Cisplatin for extensive-stage small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer [Phase 2]
Phase 2 trial comparing Topotecan plus apatinib versus Topotecan alone as second-line therapy for small-cell lung cancer is being studied. T…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid [Phase 2]
Phase 2 trial evaluating immunization of extensive-stage small cell lung cancer patients with chemotherapy with or without all-trans retinoi…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for radiation therapy in extensive-stage small cell lung cancer; results posted after completion.
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) [Phase 2]
Phase 2 clinical trial update evaluating memory outcomes and MRI changes with hippocampus-avoidance prophylactic cranial irradiation in smal…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC [Phase 3]
Phase 3 trial comparing irinotecan plus cisplatin (IP) versus etoposide plus cisplatin (EP) after EP/TRT for limited-stage small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Validation of the MiCK Assay
The MiCK Assay validation trial (NCT01770665) sponsored by Pierian Biosciences has been terminated, involving mesothelioma, small cell lung …
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: TF2- Small Cell Lung Cancer Radio Immunotherapy [Phase 1, Phase 2]
The clinical trial TF2 radioimmunotherapy for small cell lung cancer and non-small cell lung cancer has completed Phase 1 and Phase 2 studie…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin [Phase 3]
Phase 3 clinical trial evaluating apatinib as maintenance therapy after etoposide/cisplatin in extensive-stage small cell lung cancer; curre…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: ZD6474 in Treating Patients With Small Cell Lung Cancer [Phase 2]
The Phase 2 trial of ZD6474 for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of lepirudin in patients with recurrent or advanced small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]
An update on a Phase 2 trial evaluating chemotherapy plus radiation therapy for limited-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating cisplatin plus etoposide with or without paclitaxel in extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-07-20Clinical Trial Update: Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating liposomal SN-38 for small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy and radiation therapy for patients with limited-stage small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone [Phase 3]
Phase 3 trial comparing ipilimumab plus etoposide and platinum to etoposide and platinum alone in extensive-disease small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
This clinical trial update reports the results of a Phase 2 study of paclitaxel in patients with extensive-stage small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating a combination chemotherapy regimen for recurrent or refractory small cell lung cancer has completed.